Literature DB >> 28262238

Prevention and management of ovarian hyperstimulation syndrome.

Scott M Nelson1.   

Abstract

Ovarian hyperstimulation syndrome (OHSS) is a serious iatrogenic complication of ovarian stimulation. It is feasible to identify patients at risk, modify stimulation strategies to ameliorate risk, and initiate out-patient treatments that alter disease pathophysiology to reduce disease severity. Mitigation of OHSS risk and severity, through innovative approaches prior to treatment, during treatment and after treatment should now be standard care. This review summarizes recent developments and provides recommendations on the prevention and treatment of OHSS.
© 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IVF; Ovarian hyperstimulation syndrome (OHSS); Prevention; Treatment

Mesh:

Substances:

Year:  2017        PMID: 28262238     DOI: 10.1016/S0049-3848(17)30070-1

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  16 in total

1.  Assessing the Usefulness of Severity Markers in Women with Ovarian Hyperstimulation Syndrome.

Authors:  Aleksei Petrovich Petrenko; Camil Castelo-Branco; Dimitry Vasilevich Marshalov; Alexander Valerievich Kuligin; Efim Munevich Shifman; Elena Sergeevna Nesnova
Journal:  Reprod Sci       Date:  2020-10-15       Impact factor: 3.060

2.  Case-based discussion on the implications of exogenous estrogens in hemostasis and thrombosis: the obstetrician's view.

Authors:  Andra H James
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

3.  Sp1 regulates steroidogenic genes and LHCGR expression in primary human luteinized granulosa cells.

Authors:  Scott Convissar; Nicola J Winston; Michelle A Fierro; Humberto Scoccia; Alberuni M Zamah; Carlos Stocco
Journal:  J Steroid Biochem Mol Biol       Date:  2019-04-04       Impact factor: 4.292

4.  Ovarian hyperstimulation syndrome as a cause of acute limb ischemia.

Authors:  Paige Williams; Clifford Buckley
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-11-15

5.  An update of polycystic ovary syndrome: causes and therapeutics options.

Authors:  Abeer M Rababa'h; Bayan R Matani; Alaa Yehya
Journal:  Heliyon       Date:  2022-10-10

6.  Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI.

Authors:  Bo Sun; Yujia Ma; Lu Li; Linli Hu; Fang Wang; Yile Zhang; Shanjun Dai; Yingpu Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-19       Impact factor: 5.555

7.  Lipid Metabolic Disorders and Ovarian Hyperstimulation Syndrome: A Retrospective Analysis.

Authors:  Feifei Liu; Qi Jiang; Xuedong Sun; Yuzhen Huang; Zhenzhen Zhang; Ting Han; Yuhua Shi
Journal:  Front Physiol       Date:  2020-11-19       Impact factor: 4.566

8.  Clinical Pregnancy and Incidence of Ovarian Hyperstimulation Syndrome in High Ovarian Responders Receiving Different Doses of hCG Supplementation in a GnRH-Agonist Trigger Protocol.

Authors:  Xiuzhen Shen; Qinjie Yang; Lanfang Li; Wenhao Lu
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-25       Impact factor: 2.629

9.  The effectiveness, safety, and economic evaluation of Korean medicine for unexplained infertile women: A multi-center, prospective, observational study protocol.

Authors:  Su-Hyun Kim; Junyoung Jo; Dong-Il Kim
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

10.  Development and Validation of Prediction Model for High Ovarian Response in In Vitro Fertilization-Embryo Transfer: A Longitudinal Study.

Authors:  Xinsha Tan; Honglin Xi; Jing Yang; Wenfeng Wang
Journal:  Comput Math Methods Med       Date:  2021-10-16       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.